IL-23 Inhibitor Therapy Boosting the Tremfya Market Growth
The increasing prevalence of chronic autoimmune disorders has accelerated demand for targeted biologic therapies that offer long-term disease control and improved patient outcomes. Among these conditions, psoriatic arthritis (PsA) has emerged as a major therapeutic focus due to its progressive nature and significant impact on quality of life. The expansion of the psoriatic arthritis treatment...
0 Commentarios 0 Acciones 8 Views 0 Vista previa